These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 4387812)
1. The pharmacological actions of butidrine. A comparative study of this new beta-adrenergic receptor antagonist and its four stereoisomers. Ferrini R; Miragoli G; Croce G Arzneimittelforschung; 1968 Jul; 18(7):829-33. PubMed ID: 4387812 [No Abstract] [Full Text] [Related]
2. [Pharmacological studies with 1-isopropylamino-3-(o-allyloxyphenoxy)-2-propanol-hydrochloride, an adrenergic beta-receptor blocking agent]. Brunner H; Hedwall PR; Meier M Arzneimittelforschung; 1968 Feb; 18(2):164-70. PubMed ID: 5695373 [No Abstract] [Full Text] [Related]
3. Some pharmacological properties of four stereoisomers of butidrine, a new adrenergic beta-receptor antagonist. Ferrini R Arzneimittelforschung; 1968 Jan; 18(1):48-50. PubMed ID: 4386975 [No Abstract] [Full Text] [Related]
4. Effect of o-2-hydroxy-3-(tert.-butylamino) propoxybenzonitrile HCl (KO 1366) on beta adrenergic receptors in the cardiovascular system. Nayler WG; Tay J J Pharmacol Exp Ther; 1972 Feb; 180(2):302-16. PubMed ID: 4400889 [No Abstract] [Full Text] [Related]
5. Inotropic and chronotropic effects of two stereoisomers of butidrine, a new adrenergic beta-blocking agent, on isolated rabbit heart and rat auricles. Bertaccini G; Impicciatore M; Visioli O; Malagnino G Farmaco Sci; 1968 Mar; 23(3):183-96. PubMed ID: 5713108 [No Abstract] [Full Text] [Related]
6. Pharmacological and toxicological properties of two new beta-adrenergic receptor antagonists. Lish PM; Weikel JH; Dungan KW J Pharmacol Exp Ther; 1965 Aug; 149(2):161-73. PubMed ID: 4378558 [No Abstract] [Full Text] [Related]
7. Effects of beta-adrenoceptor blocking drugs on the chronotropic and inotropic actions of isoprenaline on the acutely denervated dog heart. Harry JD; Kappagoda CT; Linden RJ; Snow HM Br J Pharmacol; 1971 Feb; 41(2):387P-389P. PubMed ID: 4396704 [No Abstract] [Full Text] [Related]
8. Pharmacological properties of 1-(4'-nitrophenyl)-2-isopropylamino-ethanol (INPEA), a new beta-adrenergic receptor antagonist. IV. Effects of the optical isomers D (minus) and L (plus) INPEA on the arterial pressure and on the pressor responses to noradrenaline, adrenaline and isoproterenol in urethan-anesthetised rats. Murmann W; Gamba A Boll Chim Farm; 1967 Feb; 106(2):101-8. PubMed ID: 5608202 [No Abstract] [Full Text] [Related]
9. [Modifications of the electric activity of the guinea pig myocardial fiber induced by 4 stereoisomers of butidrine, a new compound with adrenergic beta receptor blockading action]. Musso E; Taccardi B Arch Int Pharmacodyn Ther; 1970 Jan; 183(1):173-89. PubMed ID: 4392359 [No Abstract] [Full Text] [Related]
10. Selective blockade of adrenoceptive beta receptors in the heart. Dunlop D; Shanks RG Br J Pharmacol Chemother; 1968 Jan; 32(1):201-18. PubMed ID: 4384337 [No Abstract] [Full Text] [Related]
11. [Effect of an adrenergic beta receptor blockader (LB 46) on various functional parameters of the rabbit heart]. Arrigo L; Macrì I; Rigon-Macrì P Boll Soc Ital Biol Sper; 1971 Oct; 47(20):650-2. PubMed ID: 4401208 [No Abstract] [Full Text] [Related]
12. Cardiopulmonary actions of 1-isopropylamino-3-(3-tolyloxy)-2-propanol hydrochloride: a new adrenergic beta receptor antagonist. Madan BR; Gupta RS; Santani DD Indian J Med Res; 1970 Feb; 58(2):246-52. PubMed ID: 4394157 [No Abstract] [Full Text] [Related]
13. [Effect of an adrenergic beta receptor blockader (D(-)INPEA) on various functional parameters of the rabbit heart]. Arrigo L; Macrì I; Rigon-Macrì P Boll Soc Ital Biol Sper; 1971 Oct; 47(20):647-50. PubMed ID: 4401207 [No Abstract] [Full Text] [Related]
14. Pharmacological actions of 1-(o-methoxyphenoxy)3-isopropylamino-2-propanol hydrochloride (S-D-1601), a new beta-blocking agent. Ferrini R; Miragoli G; Croce G Arzneimittelforschung; 1970 Aug; 20(8):1074-9. PubMed ID: 4394830 [No Abstract] [Full Text] [Related]
15. [Beta-receptor-blocking agents and their current clinical significance]. Deptalla H; Wiegershausen B Dtsch Gesundheitsw; 1968 Dec; 23(50):2353-63. PubMed ID: 4389656 [No Abstract] [Full Text] [Related]
16. Pharmacological properties of H 56-28--a beta-adrenergic receptor antagonist. Ablad B; Brogård M; Ek L Acta Pharmacol Toxicol (Copenh); 1967; 25():9-40. PubMed ID: 6072577 [No Abstract] [Full Text] [Related]
17. Beta adrenergic blocking and cardiovascular properties of two new substances, Kö 1313 and Kö 1366. Baum T; Rowles G; Shropshire AT; Gluckman MI J Pharmacol Exp Ther; 1971 Feb; 176(2):339-49. PubMed ID: 4398186 [No Abstract] [Full Text] [Related]
18. [Hemodynamic effects of a new beta-adrenergic blocking agent. Study of normal subjects in various cardiocirculatory functional conditions]. Starcich R; Barbaresi F; Bacuzzi E; Valentino RV Minerva Cardioangiol; 1966 Nov; 14(11):650-7. PubMed ID: 5999111 [No Abstract] [Full Text] [Related]
19. [Effect of isoproterenol on the hemodynamics and contractibility of the left ventricle before and after Gubernal]. Schönbeck M; Krayenbühl HP; Wirz P; Mahler F; Rutishauser W Schweiz Med Wochenschr; 1971 Jul; 101(29):1061-7. PubMed ID: 4398193 [No Abstract] [Full Text] [Related]
20. Mechanism of action of adrenergic beta-receptor blocking agents in the prevention of cyclopropane adrenaline-evoked ventricular arrhythmias in the dog. Sharma PL; Narang RS Indian J Med Res; 1968 Aug; 56(8):1256-64. PubMed ID: 5711605 [No Abstract] [Full Text] [Related] [Next] [New Search]